X-Therma Inc. is solving unmet legacy needs in the storage of biological products using convergent biomimetic nanotechnology. This solution can better enable critical biomanufacture processes, safer transport and long-term biobanking for advanced cell therapies, in vitro fertilization, organ transplants, and other rapidly growing regenerative medicine areas.
Location: United States, California, Richmond
Employees: 11-50
Total raised: $35.4M
Founded date: 2014
Investors 4
Date | Name | Website |
28.12.2021 | Dellin Inv... | dellin.inv... |
24.10.2020 | Cavendish ... | cavendishf... |
- | Lorea AG | lorea-ag.c... |
09.06.2021 | VU Venture... | vuventurep... |
Funding Rounds 2
Date | Series | Amount | Investors |
15.03.2024 | Series B | $22.4M | - |
22.12.2021 | Series A | $13M | - |
Mentions in press and media 7
Date | Title | Description | Source |
20.03.2024 | X-Therma Secures $22.4M for Breakthrough Organ Preservation ... | X-Therma, a biotech company in San Francisco, has raised $22.4M in Series B funding to advance their... | parsers.vc... |
15.03.2024 | X-Therma Raises $22.4M in Series B Funding | Xiaoxi Wei, Ph.D., Co-founder and CEO of X-Therma, with the TimeSeal® X-Therma, a San Francisco, CA-... | finsmes.co... |
14.03.2024 | X-Therma Nabs $22.4M Oversubscribed Series B | SAN FRANCISCO, CA, X-Therma has completed an oversubscribed $22.4 million Series B funding round. ... | vcnewsdail... |
22.12.2021 | X-Therma Closes $13M Series A Financing | X-Therma Inc., a Richmond, Calif.-based biotechnology company developing technology for regenerative... | finsmes.co... |
22.12.2021 | X-Therma Closes Oversubscribed $13M Series A Financing Led b... | X-Therma Inc., a biotechnology company developing breakthrough technology for regenerative medicine ... | marketscre... |
22.12.2021 | X-Therma Closes $13M Series A | RICHMOND, CA, X-Therma, a biotechnology company, has closed an oversubscribed $13M Series A fundin... | vcnewsdail... |
- | X-Therma | “At X-Therma, we're advancing regenerative medicine and organ transplantation with a novel biopreser... | fastfounde... |